N.M. Stat. § 59A-22-40
Coverage for cytologic and human papillomavirus
screening.
A. Each individual and group health insurance policy, health care plan and
certificate of health insurance delivered or issued for delivery in this state shall provide
coverage for cytologic and human papillomavirus screening for determining the
presence of precancerous or cancerous conditions and other health problems. The
coverage shall make available cytologic screening, as determined by the health care
provider in accordance with national medical standards, for women who are eighteen
years of age or older and for women who are at risk of cancer or at risk of other health
conditions that can be identified through cytologic screening. The coverage shall make
available human papillomavirus screening once every three years for women aged thirty
and older.
B. Coverage for cytologic and human papillomavirus screening may be subject to
deductibles and coinsurance consistent with those imposed on other benefits under the
same policy, plan or certificate.
C. The provisions of this section shall not apply to short-term travel, accident-only or
limited or specified-disease policies.
D. For the purposes of this section:
(1)
"cytologic screening" means a Papanicolaou test and a pelvic exam for
asymptomatic as well as symptomatic women;
(2)
"health care provider" means any person licensed within the scope of his
practice to perform cytologic and human papillomavirus screening, including physicians,
physician assistants, certified nurse midwives and certified nurse practitioners; and
(3)
"human papillomavirus screening" means a test approved by the federal
food and drug administration for detection of the human papillomavirus.